DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Gilead Sciences (NASDAQ: GILD)

104.83 0.65 (0.62%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $104.83 0.62%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $104.33
Previous Close $104.18
Daily Range $103.73 - $106.27
52-Week Range $63.50 - $116.83
Market Cap $158.2B
P/E Ratio 18.47
Dividend (Yield) $0.00 (0.0%)
Volume 13,557,687
Average Daily Volume 19,184,187
Current FY EPS $7.80





Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary

Can Biotech Duplicate Its 2014 Performance, or Is It Time to Jump Ship?

Three Motley Fool healthcare contributors share thoughts on whether biotech stocks can go higher this year.

Earnings Expectations For The Week Of February 2: Disney, Exxon, GM And More

Gasoline ‘tax cut’ in focus on energy, consumer-based earnings

The Top 10 Corporate Earnings for the Week Ahead

3 Small-Cap Biotech Stocks That Could Be Top Stocks in 2015

Portola Pharmaceuticals, Ophthotech, and Achillion Pharmaceuticals have catalysts ahead that could make them top stocks to watch this year.

Fast Money Halftime Report Final Trade From January 30

Gilead Sciences' Future in 3 Simple Slides

Three reasons that Gilead Sciences' future may prove to be bright.

Amgen Offers Impressive Upside As A New Product Cycle Begins

3 Biotech Giants That Shouldn't Pay a Dividend

Three Motley Fool contributors explain why they don't want these large-cap biotech companies to pay a dividend.

Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More

See More GILD News...

GILD's Top Competitors

GILD $104.83 (0.62%)
Current stock: GILD
AMGN $152.26 (-2.63%)
Current stock: AMGN
CELG $119.16 (-1.41%)
Current stock: CELG
$0.00 (0.00%)
Current stock: